The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online March 12, 2007
doi:10.1084/jem.20061287
The Journal of Experimental Medicine, Vol. 204, No. 3, 667-680
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Dunn et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 3795K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dunn, C.
Right arrow Articles by Maini, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dunn, C.
Right arrow Articles by Maini, M. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage

Claire Dunn1, Maurizia Brunetto4, Gary Reynolds5, Theodoros Christophides1, Patrick T. Kennedy2, Pietro Lampertico6, Abhishek Das1, A. Ross Lopes1, Persephone Borrow7, Kevin Williams5, Elizabeth Humphreys5, Simon Afford5, David H. Adams5, Antonio Bertoletti2, and Mala K. Maini1,3

1 Division of Infection and Immunity, 2 Institute of Hepatology, and 3 Centre for Sexual Health and HIV Research, University College London, London W1T 4JF, UK
4 U.O. Gastroenterologia ed Epatologia, Spedali Riuniti di Santa Chiara, I-56124 Pisa, Italy
5 Institute of Biomedical Research, University of Birmingham, Birmingham B15 2TT, UK
6 Gastroenterology Unit, Fondazione Policlinico, University of Milan, 20122 Milan, Italy
7 Nuffield Department of Clinical Medicine and The Jenner Institute, University of Oxford, Oxford OX3 9DU, UK

CORRESPONDENCE Mala K. Maini: m.maini{at}ucl.ac.uk

Hepatitis B virus (HBV) causes chronic infection in more than 350 million people worldwide. It replicates in hepatocytes but is non-cytopathic; liver damage is thought to be immune mediated. Here, we investigated the role of innate immune responses in mediating liver damage in patients with chronic HBV infection. Longitudinal analysis revealed a temporal correlation between flares of liver inflammation and fluctuations in interleukin (IL)-8, interferon (IFN)-{alpha}, and natural killer (NK) cell expression of tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) directly ex vivo. A cross-sectional study confirmed these findings in patients with HBV-related liver inflammation compared with healthy carriers. Activated, TRAIL-expressing NK cells were further enriched in the liver of patients with chronic HBV infection, while their hepatocytes expressed increased levels of a TRAIL death–inducing receptor. IFN-{alpha} concentrations found in patients were capable of activating NK cells to induce TRAIL-mediated hepatocyte apoptosis in vitro. The pathogenic potential of this pathway could be further enhanced by the ability of the IFN-{alpha}/IL-8 combination to dysregulate the balance of death-inducing and regulatory TRAIL receptors expressed on hepatocytes. We conclude that NK cells may contribute to liver inflammation by TRAIL-mediated death of hepatocytes and demonstrate that this non-antigen–specific mechanism can be switched on by cytokines produced during active HBV infection.


Abbreviations used: ALT, alanine transaminase; CBA, cytometric bead array; eAg-CHB, e antigen negative chronic hepatitis B; HBV, hepatitis B virus; TRAIL, TNF-related apoptosis-inducing ligand.

A. Bertoletti's present address is CMM, A*Star, Singapore 138668.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS